Ready 8-Ks
25
Latest filing
May 8, 2026, 7:59 PM ET
Top materiality
0.85
Event mix
earnings ×9 · other_material ×4 · leadership ×4
Sentiment
12 pos · 2 neg · 11 neu
Latest earnings
reported 2026-Q1
-
Itron authorizes $200M share repurchase program over 18 months
Board authorized up to $200M stock buyback over 18 months starting May 8, 2026.
-
Itron Q1 revenue down 3% to $587M, GAAP EPS $1.18 vs $1.42, non-GAAP EPS $1.49
Revenue $587M, down 3% YoY; GAAP net income $53M ($1.18 diluted EPS), down from $65M ($1.42).
-
Itron reports unauthorized third-party access to systems; investigation ongoing, operations continue
Unauthorized access discovered April 13, 2026; response plan activated and law enforcement notified.
-
Itron prices $700M zero-coupon convertible notes due 2032, upsized; concurrent $100M share repurchase
$700M principal 0.00% convertible senior notes due 2032; initial conversion price $123.77/share (30% premium to $95.21).
-
Itron Q4 beats: GAAP EPS $2.21 vs $1.26; Non-GAAP $2.46; Revenue $572M; Guides FY26 rev $2.35-2.45B
Q4 revenue $572M (-7% YoY); GAAP net income $102M, diluted EPS $2.21 (vs $1.26).
-
Itron to acquire Locusview for $525M in cash; close expected Jan 2026
Purchase price of $525 million funded from cash on hand; working capital adjustments post-close.
-
Itron Q3 revenue down 5% to $582M, gross margin up 360 bps; acquires Urbint for $325M
GAAP diluted EPS $1.41 vs $1.70 YoY; Non-GAAP diluted EPS $1.54 vs $1.84.
-
Itron to acquire Urbint for $325M in cash, expected close Q4 2025
Purchase price $325M, funded from cash on hand.
-
Itron reports Q2 GAAP EPS $1.47, non-GAAP EPS $1.62; raises full-year 2025 outlook
GAAP net income $68M ($1.47 diluted EPS); non-GAAP diluted EPS $1.62, up $0.41 YoY.
-
Itron shareholders double authorized common shares to 150M, approve charter amendments
Authorized common stock increased from 75M to 150M shares, effective May 8, 2025.
-
Itron Q1 2025: Revenue $607M (+1%), GAAP EPS $1.42 (+$0.30), Non-GAAP EPS $1.52 (+$0.28), backlog $4.7B
Revenue $607M (+1% YoY); gross margin 35.8% (+180 bps) on favorable product mix.
-
Itron Q4 revenue $613M (+6% YoY); GAAP EPS $1.26; full-year record backlog $4.7B
Q4 revenue $613M, up 6% YoY; GAAP net income $58M ($1.26 diluted EPS); Non-GAAP EPS $1.35.
-
Itron Q3 2024: Revenue $615M (+10%), GAAP EPS $1.70, Non-GAAP EPS $1.84; guides FY24 revenue $2.428-$2.438B
Revenue of $615M (+10% YoY); gross margin 34.1% (+70 bps); GAAP net income $78M ($1.70 EPS) vs. $40M ($0.87 EPS).
-
Itron board authorizes $100M share repurchase program; appoints new CAO
David M. Wright appointed VP, Corporate Controller & Chief Accounting Officer effective Sept 19, 2024; no new compensation arrangement.
-
Itron Q2 2024 revenue $609M (+13% YoY), GAAP EPS $1.10, raises FY 2024 guidance
Revenue $609M (+13% YoY); gross margin 34.6% (+250 bps).
-
Itron prices $700M 1.375% convertible notes due 2030; conversion premium 27.5%
Issued $700M of 1.375% Convertible Senior Notes due July 15, 2030; initial purchasers exercised $105M option.
-
Itron Q1 revenue $603M (+22% YoY); GAAP EPS $1.12 vs loss year ago; guides Q2 non-GAAP EPS $0.90-1.00
Revenue $603M (+22% YoY); gross margin 34.0% (+240bps) on higher margin mix and operational efficiencies.